Makary's exit creates new uncertainty at FDA

Marty Makary's departure from the FDA creates uncertainty and may not solve organizational upheaval. The Senate will need to confirm another commissioner while considering other nominees. Makary's exit follows internal criticism and complaints about unpredictable regulatory decisions.